SCTbio Presentation: Setting Yourself Up for Clinical Success: How do you Increase Your Probability of Clinical Success When Translating from the Lab to GMP?
Wednesday, September 4, 2024 10:15 AM - 10:30 AM
Room R17 – Global Showcase B
Global Showcase Presentation
Presenter:
- Pascale Charbonnel, Chief Business Officer, SCT Cell Manufacturing - SCTbio
CGT developers are facing many challenges in transitioning from lab to clinical settings. During our presentation, we’ll explore critical topics:
- GMP Readiness: What does it take to be GMP compliant?
- Consistent Product Manufacturing: How can you consistently scale up and out to meet clinical dose requirements? What factors contribute to an all-inclusive budget? Are there shortcuts for translational success?
- Selecting Your CDMO Partner: What are the top criteria when selecting a CDMO partner
- Pathway to GMP: How to gain a comprehensive understanding of the regulatory landscape.
- Scaling: Explore viable manufacturing options to consistently produce sufficient clinical doses.
- Choosing Your CDMO Partner: Key considerations for selecting the right collaborator. How do you ensure your partner is the best match for you. What steps can you take to build a solid foundations for a successful partnership?
SPONSORED BY:
